Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia.
There are 2 types of vulvar intraepithelial neoplasia (VIN): warty-basaloid and differentiated. Differentiated VIN is uncommon and seldom diagnosed prior to carcinoma and, traditionally, is not graded. There are currently 3 grading systems for warty-basaloid VIN: the World Health Organization (WHO) 3 grade system of VIN 1-3, a 2 grade system of low and high grade vulvar intraepithelial lesions, and the revised International Society for the Study of Vulvovaginal Disease (ISSVD) classification which has no grading of VIN. According to the ISSVD, VIN 1 should be abolished and VIN 2 and 3 combined into a single category, simply termed warty-basaloid VIN. To determine the best system for grading warty-basaloid VIN and learn more about differentiated VIN, we reviewed the pathology of 164 consecutive women with VIN. Of these, 134 (82.3%) had warty-basaloid VIN, 29 (18.2%) had differentiated VIN, and 1 had both. Of warty-basaloid VIN cases, 4 had VIN 1, 13 VIN 2, and 118 VIN 3 when graded according to the WHO. All VIN 1 occurred in condylomata acuminata. VIN 2 and 3 were distinguished only by degree of abnormality. Differentiated VIN was diagnosed before SCC in only 7 cases (26.7%). Because the only VIN 1 cases seen were in condylomata acuminata and because VIN 2 and 3 were difficult to distinguish and there appears little clinical reason to do so, our study supports the ISSVD proposal that VIN 1 be abolished and VIN 2 and 3 be combined. There needs to be more clinical awareness of vulvar conditions, so that differentiated VIN is biopsied before cancer has supervened.
Scurry
James
J
Gynaecological Cancer Centre, Royal Hospital for Women, and University of New South Wales, Sydney, New South Wales, Australia. jscurry@bigpond.com
Campion
Michael
M
Scurry
Bonnie
B
Kim
Soo Nyung
SN
Hacker
Neville
N
D002278:Carcinoma in Situ / Q000145:classification / Q000473:pathology*; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D005260:Female; D006801:Humans; D014846:Vulvar Neoplasms / Q000145:classification / Q000473:pathology*; D014944:World Health Organization